Showing all 2 results
Lamivudine & Zidovudine tablets
FreeProduct Composition & Strength
We supply this product in the internationally standardized Fixed-Dose Combination (FDC) required for therapeutic compliance.
Active Ingredient Strength (per Tablet) Primary Clinical Function Lamivudine (3TC) IP/BP/USP 150 mg The Chain Terminator: High potency, low toxicity. Zidovudine (AZT) IP/BP/USP 300 mg The Foundation: Proven efficacy in preventing replication. Excipients Pharma Grade The Matrix: Ensures stability of the sensitive FDC. Zidovudine Tablet
FreeProduct Composition & Strength
We supply this product in standardized strengths optimized for both monotherapy (in specific PMTCT cases) and combination therapy (HAART).
Active Ingredient Strength Primary Clinical Target Zidovudine IP/BP/USP 300 mg The Foundation: Standard dose for adult HIV management. Excipients Pharma Grade The Matrix: Ensures shelf-life stability and rapid absorption.
